Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRFS | CORT | CRNX | ||
| Company | Grifols S.A. ADR | Corcept Therapeutics | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.65 | 50.58 | 52.28 | ||
| High | 7.66 | 52.35 | 54.25 | ||
| Low | 7.45 | 50.02 | 51.73 | ||
| Last | 7.51 | 51.40 | 53.60 | ||
| Change | -0.21 | +0.25 | +0.86 | ||
| % Change | -2.72% | +0.49% | +1.63% | ||
| Volume | 1,796,900 | 2,456,200 | 1,940,400 | ||
| 20-Day Average Volume | 1,339,215 | 910,860 | 760,260 | ||
| Previous Close | 7.72 | 51.15 | 52.74 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.63 | 57.34 | 56.15 | ||
| 20-Day Raw Stochastic | 34.43% | 11.31% | 29.24% | ||
| 20-Day Relative Strength | 44.53% | 43.73% | 45.12% | ||
| Weighted Alpha | -7.39 | +78.01 | +34.17 | ||
| Today's Opinion | 56% Sell | 56% Buy | 24% Buy | ||
| Previous Opinion | 8% Sell | 56% Buy | 24% Buy | ||
| Last Month's Opinion | 64% Buy | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.46% since 12/13/24 | -7.22% since 12/13/24 | -0.11% since 12/13/24 | ||
| Low | 7.41 on 12/18/24 | 50.02 on 12/20/24 | 50.81 on 12/19/24 | ||
| High | 8.13 on 12/17/24 | 56.46 on 12/16/24 | 56.15 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -12.67% since 11/20/24 | -8.36% since 11/20/24 | -4.41% since 11/20/24 | ||
| Low | 6.83 on 12/02/24 | 50.02 on 12/20/24 | 50.81 on 12/19/24 | ||
| High | 8.81 on 11/22/24 | 62.22 on 12/04/24 | 60.34 on 12/11/24 | ||
| 3-Month | |||||
| %Chg | -16.09% since 09/20/24 | +21.66% since 09/20/24 | +0.85% since 09/20/24 | ||
| Low | 6.83 on 12/02/24 | 41.92 on 09/23/24 | 49.13 on 09/24/24 | ||
| High | 9.96 on 11/08/24 | 62.22 on 12/04/24 | 62.53 on 11/14/24 | ||
| 6-Month | |||||
| %Chg | +7.59% since 06/20/24 | +74.83% since 06/20/24 | +21.24% since 06/20/24 | ||
| Low | 5.79 on 06/27/24 | 29.18 on 06/21/24 | 41.01 on 06/26/24 | ||
| High | 9.96 on 11/08/24 | 62.22 on 12/04/24 | 62.53 on 11/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,163,576 | 5,385,435 | 4,970,756 | ||
| Shares Outstanding, K | 687,560 | 104,775 | 92,738 | ||
| Annual Sales | 7,134,500,000 | 482,380,000 | 4,010,000 | ||
| Annual Net Income | 64,200,000 | 106,140,000 | -214,530,000 | ||
| Last Quarter Sales | 1,971,530,000 | 182,550,000 | 400,000 | ||
| Last Quarter Net Income | 56,840,000 | 47,210,000 | -74,050,000 | ||
| 60-Month Beta | 0.43 | 0.51 | 0.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 07/30/24 | 0.41 on 10/30/24 | -0.96 on 11/12/24 | ||
| Latest Earnings Date | 08/01/24 | 10/30/24 | 11/12/24 | ||
| Most Recent Dividend | 0.370 on 06/03/21 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/03/21 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.60 | 0.00 | ||